KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

AIROL 0.05 % LOTION

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

0.05 %

 

GENERIC NAME:

TRETINOIN

 

MANUFACTURER:

LAB.PIERRE FABRE MEDICAMENT

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Acne vulgaris

Hyperpigmentation, facial

Wrinkles, facial

 

SIDE EFFECTS:

Burning or stinging sensation of skin, severe

erythema, severe

hypopigmentation of treated skin

scaling of skin, severe

unusually dry skin, severe

Hyperpigmentation of treated skin

Burning sensation, stinging, or tingling of skin, mild

erythema, mild

scaling of skin, mild

unusually dry skin, mild

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Dermatitis, seborrheic

>> Eczema

Sensitivity to tretinoin

>> Sunburn

 

ADULT DOSE:

Acne vulgaris- Initial: Topical, to the skin of affected areas, once a day at bedtime . After the first seven to ten days of use, dose may be increased to two times a day if excessive drying of skin has not occurred . Maintenance: Topical, to the skin of affected areas, once a day at bedtime or less often as needed . [Keratosis follicularis] or [Verruca plana] - Topical, to the skin of affected areas, one or two times a day .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT